Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Status:
Completed
Trial end date:
2013-08-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the potential of denosumab to treat Hypercalcemia
of Malignancy in patients with elevated serum calcium who do not respond to recent treatment
with intravenous bisphosphonates by lowering corrected serum calcium Phase:
Phase 2